CSIMarket
 


Plx Pharma Inc   (PLXP)
Other Ticker:  
 

Cumulative Plx Pharma Inc 's Leverage Ratio for Trailing Twelve Months Period

PLXP's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

PLXP Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -67.03 % -58.89 % -41.85 % - -
Y / Y Total Liabilities Growth -66.2 % -41.09 % -1.57 % 44.63 % 158.09 %
Leverage Ratio for Trailing Twelve Months Period 1.29 1.39 1.28 1.12 1.51
Total Ranking # 2645 # 2766 # 2814 # 2632 # 2629
Seq. Equity Growth -38.23 % -36.5 % -27.19 % 15.45 % -22.99 %
Seq. Total Liabilities Growth -21.68 % -22.38 % -14.23 % -35.18 % 36.52 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2022
On the trailing twelve months basis Due to debt repayement of -21.68% Plx Pharma Inc decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 1.29, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 454 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Plx Pharma Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are PLXP's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 455
Sector # 900
S&P 500 # 2986


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
6.61 2.22 0.79
(Mar 31 2019)   (Sep 30 2017)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Sarepta Therapeutics Inc   3.54 
Collegium Pharmaceutical Inc   3.53 
Silence Therapeutics Plc  3.52 
Adc Therapeutics Sa  3.50 
Evelo Biosciences Inc   3.46 
Rockwell Medical inc   3.42 
Avalo Therapeutics Inc   3.40 
Xeris Biopharma Holdings Inc   3.38 
Agile Therapeutics Inc  3.30 
Journey Medical Corporation  3.27 
Bellicum Pharmaceuticals Inc   3.22 
Teva Pharmaceutical Industries Limited  3.21 
Impel Pharmaceuticals Inc   3.04 
Aptevo Therapeutics Inc   3.04 
Fibrogen Inc   3.03 
Cv Sciences Inc   3.00 
Nls Pharmaceutics Ltd   2.93 
Gossamer Bio Inc   2.93 
Wave Life Sciences Ltd   2.89 
Cartesian Therapeutics Inc   2.89 
Societal Cdmo Inc   2.89 
Ionis Pharmaceuticals Inc  2.88 
Global Blood Therapeutics Inc.  2.88 
Apellis Pharmaceuticals Inc   2.81 
China Pharma Holdings Inc   2.80 
Vaxxinity Inc   2.77 
Molecular Templates inc   2.75 
Panbela Therapeutics Inc   2.70 
Effector Therapeutics Inc   2.70 
Mei Pharma Inc   2.68 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com